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Immune cells navigate through different environments where they experience different mechanical
forces. Responses to external forces are determined by the mechanical properties of a cell and they
depend to a large extent on the actin-rich cell cortex. We report here that Myo1G, a previously
uncharacterised member of class I myosins, is expressed speciﬁcally in haematopoietic tissues
and cells. It is associated with the plasma membrane. This association is dependent on a conserved
PH-domain-like myosin I tail homology motif and the head domain. However, the head domain does
not need to be a functional motor. Knockdown of Myo1G in Jurkat cells decreased cell elasticity sig-
niﬁcantly. We propose that Myo1G regulates cell elasticity by deformations of the actin network at
the cell cortex.
Structured summary:
MINT-7307273:MYO1G (uniprotkb:B0I1T2) and Actin (uniprotkb:P60709) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7307283: TfR (uniprotkb:P02786) and MYO1G (uniprotkb:B0I1T2) colocalize (MI:0403) by cosedi-
mentation through density gradients (MI:0029)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Class I myosins are single-headed actin-based motor molecules
that are widely expressed. Myo1G, one of eight class I members ex-
pressed in mammals (Myo1a–Myo1h), has been found in choles-
terol-rich detergent resistant membrane fragments from
neutrophils and to be enriched in fractions of membrane and
microvilli from peripheral blood T-lymphocytes and a mouse
pre-B lymphocyte cell line [1,2]. Based on sequence homology,
Myo1G forms a subclass together with Myo1d (named previously
myr 4). Class I myosins consist of a N-terminal motor domain, a
myosin light chain binding domain with variable numbers of IQ-
motifs, and a C-terminal tail domain. This tail domain is rich in ba-
sic residues and associates with membranes [3–7]. Class I myosins
have been implicated in various cellular processes relying on actin-
dependent membrane dynamics such as endocytosis, secretion,
adhesion, motility and regulation of mechanosensitive channels
[8]. Myo1d has been reported to regulate endocytic membrane
trafﬁcking along the recycling pathway in epithelial MDCK cellschemical Societies. Published by E
meine Zoologie und Genetik,
149 Münster, Germany. Fax:
ler).[9]. In Drosophila melanogaster the loss of Myo31DF, a Myo1d
ortholog, causes a complete reversal of the left/right axis with
the gut, testis and spermiduct looping sinistrally instead of dextral-
ly [10,11].
Cells face not only a complex biochemical, but also a diverse bio-
mechanical environment. They sense and respond to different
mechanical forces and convert them into biochemical signals
[12,13]. Nearly all cells in the body are continuously stretched and
squeezed. In particular immune cells such as T-cells that patrol be-
tween different organs and tissues are exposed to differentmechan-
ical forces. The mechanical properties such as cell elasticity are
hence important for cell function. Elasticity of cells is determined
to a large extent by the actin cytoskeleton. Myosins might control
internal tension and hence the elasticity of cells. Indeed, the simul-
taneous loss of multiple class I myosins in the slimemold Dictyoste-
lium discoideum resulted in a decrease of cortical tension, whereas
overexpression of class I myosins increased cortical tension [14].
Mouse enterocytes that do not express Myo1A exhibited a reduced
membrane tension and conversely the overexpression of several
mammalian class I myosins increased membrane tension [15].
We report here the initial characterization of Myo1G, a class I
myosin expressed speciﬁcally in the haematopoietic system. It
associates with the plasma membrane through a PH-like domain
and contributes to the elasticity of Jurkat T-cells.lsevier B.V. All rights reserved.
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2.1. Cell culture and transfections
B16-F1 mouse melanoma (ATCC CRL-6323) and Jurkat (ATCC
TIB-152) cells were cultured in high glucose DMEM (PAA, Ger-
many) and RPMI-1640 (ATCC Cat No. 30-2001), respectively, sup-
plemented with 10% heat inactivated fetal calf serum, 2 mM L-
glutamine (Invitrogen, Karlsruhe, Germany), 50 U/ml penicillin
(Invitrogen), and 0.05 mg/ml streptomycin (Invitrogen). They were
incubated at 37 C in a humidiﬁed atmosphere with 5% CO2. B16-
F1 cells were cultured on 60-mm diameter dishes to 60% conﬂu-
ence and transfected by using SuperFect reagent (QIAGEN, Hilden,
Germany) as instructed by the manufacturer.
2.2. Subcellular fractionation and tissue preparation
Jurkat cells were harvested in PBS and centrifuged at 100g for
10 min. Pelleted cellswere resuspended in ice-cold hypotonic buffer
(10 mM KCl, 2 mM MgCl2, 5 mM HEPES, pH 7.4) and incubated for
15 min on ice. The cell suspension was then passed through a 26G
needle for 20 times. The lysed cells were centrifuged at 500g for
10 min at 4 C to separate the PNS (post nuclear supernatant) and
nuclear pellet fractions. The PNS was collected and mixed with a
66% (w/w) sucrose solutionbefore itwas carefully layeredat thebot-
tom of a pre-made 25–55% (w/w) continuous sucrose gradient. The
gradientwascentrifuged inaBeckmannultracentrifugeSW-41rotor
at 22,000 rpm and 4 C for 22 h. Fractions were collected starting
from the bottom of the tube. Equal volumes of the fractions were
then resolved by 7.5% SDS–PAGE, transferred to PVDF membrane
and probed for Myo1G and transferrin receptor.
Different mouse tissues were homogenised by a dounce homog-
eniser in homogenisation buffer (0.32 M sucrose, 15 mM HEPES,
pH 7.4) and the protein concentration was determined by the
method of Bradford. Equal amounts of proteins were then resolved
by 7.5% SDS–PAGE and probed for Myo1G.2.3. Plasmid constructs and antibodies
Myo1G cDNA was synthesized by RT-PCR from total RNA iso-
lated from mouse spleen. Constructs encompassing different re-
gions of Myo1G, namely full length Myo1G, IQ+tail (aa 718–
1024), tail (aa 762–1024) and tail homology motif (aa 824–938)
were cloned in to pEGFP-C1 vector between BglII and SalI sites.
The mutations in the head domain (G111R, R167C) and the ‘PH-
like’ domain (K883A, R893A) were introduced by Quick-change
Site-Directed Mutagenesis (Stratagene) and conﬁrmed by sequenc-
ing. Antibodies against Myo1G were raised against a synthetic pep-
tide (aa 7–19, MEDEEGPEYGKPDC) in a rabbit (758). Alternatively,
Myo 1G antibodies were purchased from Rockland (cat no. 600-
401-959). Transferrin receptor antibody was from cymbus biotech-
nology Ltd. (Cat no. CBL137B). Antibodies against Myo 1B (Tü 23)
were raised against the fusion protein encoding amino acids
590–690 of rat Myo1B. Myo 1C (Tü 45) antibodies were raised
against a synthetic peptide (FVLHVQREDSKQKGDC). Myo 1D
(SA482) [9] and Myo1E (Tü 58) [16] antibodies have been de-
scribed previously.Fig. 1. Myo1G is expressed speciﬁcally in haematopoietic cells. Expression of
Myo1G was analysed in different tissues and cell types by immunoblotting. Tissue
and cell homogenates were prepared as described in Section 2. (A) Equal amounts of
protein were loaded from each tissue homogenate and (B) from different cell lines
and probed with Myo1G antibody. Equal protein loading of tissue homogenates was
conﬁrmed by staining a corresponding gel with Coomassie blue. Tissues and cell
lines are indicated. 32-D, myeloblast like cell line; BMDC day-5, bone marrow
derived dendritic cells cultured for 5 days in vitro; RAW 264.7, macrophage cell
line; DC2.4, dendritic cell line; Raji, B-cell line; Jurkat, T cell line; PMN, mouse poly-
morphonuclear leucocytes.2.4. Silencing of Myo1G in Jurkat cells
For silencing of Myo1G expression, Jurkat cells were transfected
with 8 ll of 20 lM stock On-Target plus SMART pool siRNA (cat#
L-025326-01, Dharmacon) using the Amaxa Nucleofector II system
speciﬁc for Jurkat cells. On-target plus non-targeting pool siRNA
were used as controls (catalog #D-001810-01-05, Dharmacon).The siRNA mediated Myo1G knockdown was veriﬁed by western
blot at 72 h post-transfection and quantiﬁed by ImageJ. The trans-
fection efﬁciency of Jurkat cells by siRNA was determined with
FACS using FITC-labelled siRNA. The siRNAs targeting human
MYO1G used in this study were as follows: 50-CUGUUUGCUCAGC-
GACUAA-30, 50-GCACCAUCACUGACCGAAU-30, 50-CGUCAACAGUU-
UCGAGCAG-30, 50-GCAAUGAAGCACCGGUCCA-30.
2.5. Immunoﬂuorescence microscopy and image acquisition
B16-F1 cells were replated on sterile coverslips coated with
mouse laminin (25 lg/ml, 1 h) 24 h after transfection and incu-
bated for an additional 4 h before ﬁxation. Jurkat cells were plated
for 1 h on human ﬁbronectin (10 lg/ml) coated glass cover slips
before ﬁxation and immunostaining. Cells were washed with PBS
to remove unattached cells, ﬁxed with 4% paraformaldehyde for
20 min and washed twice with PBS. They were then permeabilized
with 0.1% Triton X-100 in PBS for 1 min and blocked with 2% BSA in
PBS for 30 min to prevent nonspeciﬁc binding. Cells were incu-
bated with primary antibodies in 1% BSA for 1 h at room tempera-
ture, followed by washing thrice with PBS and incubation with
ﬂuorescently labelled secondary antibodies in 1% BSA for 1 h at
room temperature along with Texas red-phalloidin to stain actin
ﬁlaments. The cells were washed thrice with PBS and mounted in
mowiol. Jurkat cells were viewed using a confocal microscope
(Zeiss LSM 510, 63X oil immersion, NA 1.4) whereas B16-F1 mela-
noma cells were viewed using an epiﬂuorescence microscope
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sion CS2).
2.6. Force spectroscopy of Jurkat cells
Jurkat cells were plated on ﬁbronectin coated coverslips (10 lg/
ml) and brieﬂy washed with PBS. Calibration, elasticity measure-
ments and data processing were performed as described [17–19]
using a Nanoscope III Multimode-AFM (Veeco Instruments, Santa
Barbara, California, USA). All measurements were carried out in a
ﬂuid cell at 37 C (MMFHTR-2 Air and Fluid Sample Heater, Veeco
Instruments). Colloidal probes with a sphere radius of 0.5 lmwere
used for this work (PT.PS, Novascan Technologies, Armes, IA, USA).
Probes were placed under optical control (OMV-PAL, Veeco Instru-Fig. 2. Myo1G localizes to the plasma membrane. The subcellular localization of Myo
fractionation as described in Section 2. (A) Myo1G was labelled using rabbit anti-Myo1G
labelled with TexasRed Phalloidin. Confocal composite images (top row) and confoca
supernatant of Jurkat cells was subjected to fractionation on a linear sucrose density gr
distribution of Myo 1G (1G) and transferrin receptor (TfR) was monitored by separatingments) over the center of the cells and force–distance curves were
obtained with a constant approach velocity of 1 lm/s. Each cell
was indented once using a constant loading force of 2 nN. The
force–distance curves were analysed 200 nm from the contact
point of the cell to obtain Young’s modulus (E).
3. Results
3.1. Myo1G is expressed speciﬁcally in haematopoietic tissues and cells
The expression patterns of class I myosin’s differ greatly in mul-
ti-cellular organisms. To determine the tissue distribution of
Myo1G, we used antibodies that speciﬁcally recognized EGFP-
Myo1G in transfected B16-F1 melanoma cells (data not shown).1G in Jurkat cells was analysed by indirect immunoﬂuorescence and subcellular
antibody and an AlexaFluor 488 goat anti-rabbit secondary antibody. F-actin was
l midplane sections (bottom row) are shown. Scale bar, 5 lm. The postnuclear
adient. The densities of different fractions were analysed by refractometry (B). The
equal volumes of the collected fractions by SDS–PAGE and immunoblotting (C).
496 B. Olety et al. / FEBS Letters 584 (2010) 493–499Myo1G was detected in adult tissues of the immune system such
as thymus, lymph nodes and spleen, but not in brain, lung, heart,
liver, small intestine, testis, and kidney (Fig. 1A). It was expressed
in mouse PMN leucocytes, bone marrow derived dendritic cells and
in several hematopoietic cell lines that were of macrophage, B-, T-,
and dendritic cell origin (Fig. 1B).
3.2. Myo 1G is associated with the plasma membrane
As a ﬁrst step towards establishing potential functions of
Myo1G, we analysed its subcellular distribution in Jurkat cells
(Fig. 2). Confocal ﬂuorescence microscopy revealed that Myo1G
was associated with the plasma membrane in Jurkat cells
(Fig. 2A). The cell surface of Jurkat cells is covered by highly irreg-
ular cell protrusions as seen in a midplane confocal section leading
to a speckled appearance of the ﬂuorescence in composite confocal
images. Subcellular fractionation of Jurkat cells conﬁrmed the asso-
ciation of Myo1G with the plasma membrane. Fractions containing
Myo1G exhibited a density of 1.14–1.16 g/cm3 that corresponds to
the density expected of the plasma membrane (1.16 g/cm3)
(Fig. 2B). Myo1G co-fractionated with the transferrin receptor
(TfR) that served as a marker for the plasma membrane (Fig. 2C).
Membranes derived from the endoplasmic reticulum fractionate
in an overlapping, but not identical manner to the plasma mem-
brane. Together, these results demonstrate that Myo1G localises
to the plasma membrane.Fig. 3. Targeting of Myo1G to the plasma membrane of B16-F1 mouse melanoma cells
(green) and viewed in the ﬂuorescence microscope. Some cells were simultaneously labe
G111R; (C, C0), EGFP-Myo1G R167C. A–C EGFP ﬂuorescence and A0–C0 corresponding F-a
EGFP-Myo1G tail homology motif (AA 824–938). Scale bars, 10 lm.3.3. Targeting of Myo1G to the plasma membrane
We next investigated how Myo1G is targeted to the plasma
membrane. For that purpose we generated various mutated and
truncated constructs of Myo1G and transiently transfected them
into B16-F1 mouse melanoma cells. Although B16-F1 cells do not
express detectable amounts of Myo1G, Myo1G fused either at the
N- or C-terminus of EGFP localized to the plasma membrane
(Fig. 3A and data not shown). A functional motor domain was
not necessary for proper subcellular localization (Fig. 3B and C).
Introduction of a point mutation in the nucleotide-binding P-loop
(G111R; Myo1GG111R) that is predicted to abolish nucleotide-bind-
ing [20] and block the chemo-mechanical cycling of Myo1G in the
nucleotide-free state, did not change the localization in a signiﬁ-
cant manner (Fig. 3B). Similarly, a point mutation (R167C;
Myo1GR167C) predicted to abolish ATP hydrolysis [21,22] and block
cycling in the ATP-bound state did not block targeting to the plas-
ma membrane (Fig. 3C). Occasionally, the mutant Myo1GG111R
exhibited a slightly increased cytosolic pool. These results indi-
cated that a functional motor domain that cycles between different
nucleotide-binding states is not necessary for Myo1G targeting to
the plasma membrane, but may increase it somewhat. Overexpres-
sion of the mentioned constructs did not result in any obvious
changes of the actin cytoskeleton (Fig. 3A0–C0).
It has been previously reported that class I short tailed myosin’s
have a PH-like domain characterised by a b1-loop-b2 motif in their. B16-F1 cells were transiently transfected with different EGFP-Myo1G constructs
lled for F-actin with TexasRed-phalloidin. (A, A0), EGFP-Myo1G; (B, B0), EGFP-Myo1G
ctin stainings. (D) EGFP-Myo1G K883A-R893A; (E) EGFP-IQ+tail; (F) EGFP-tail; (G)
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to bind to phosphoinositide-(4,5)-bis-phosphate on the plasma
membrane [23]. To check if this is also the case for Myo1G, we mu-
tated two conserved basic residues in the PH-like domain to ala-
nine residues (K883A, R893A). These two point mutations
abolished plasma membrane localization and redistributed Myo1G
to the cytosol (Fig. 3D). Interestingly, we found that the motor do-
main of Myo1G is essential for proper localization. The truncated
constructs IQ’s+tail and tail localized preferentially to the nucleus
and only a minor fraction localized to the plasma membrane
(Fig. 3E and F). We have previously identiﬁed a conserved myosin
I tail homology motif [24]. This motif encompasses the PH-like do-
main and spans in mouse Myo1G amino acids 824–938. Expression
of this myosin I tail homology motif revealed that it localized in a
similar manner as IQ+tail and tail. It was found in the nucleus and
at the plasma membrane (Fig. 3G). Together these data indicate
that both the PH-Like domain and the motor domain of Myo1G
contribute to the subcellular targeting of Myo 1G in cells.3.4. Knockdown of Myo1G decreases cell elasticity
Since Myo1G can interact with F-actin and is speciﬁcally local-
ized at the plasma membrane, we asked if Myo1G affects cell elas-
ticity. To test this, we depleted Jurkat cells of Myo1G by siRNA
(Fig. 4A). Seventy two hours post nucleofection, the amount of
Myo1G was reduced by 69%. Nucleofection of Jurkat cells with
FITC-siRNA demonstrated that the majority of cells (89%) had ta-
ken up the siRNA (Fig. 4B). Class I myosins might act redundantly.
Therefore, we investigated the expression of several other class I
myosins in Jurkat cells that had been treated with Myo1G siRNA
or non-targeting siRNA (Fig. 4A). We detected the expression of
Myo1B splice variants, Myo1C and weakly of Myo1E, but not of
Myo 1D, the closest relative of Myo 1G. No changes in their expres-
sion levels were observed in Jurkat cells that had been depleted of
Myo 1G with siRNA. To determine the elasticity of adherent Jurkat
cells, we measured the force–indentation relationship. We in-
dented the cells with a spherical glass bead mounted to an AFM
cantilever (Fig. 5). The force–indentation data were then processed
to calculate elasticity [17] that is referred to as Young’s Modulus
(E) and is given in Pascals (Pa). Elasticity describes the tendency
of an object to deform along an axis when opposing forces are ap-
plied along that axis. It is a property of the constituent material and
does not depend on size, shape and boundary conditions. Jurkat
cells depleted of Myo1G showed a signiﬁcantly lower Young’s
modulus {E = 483 Pa ± 14 (SEM), n = 104} compared to the cells
transfected with non-targeting siRNA {E = 602 Pa ± 27 (SEM),
n = 98} (Fig. 5). Untransfected Jurkat cells exhibited a similar
Young’s modulus {E = 600 Pa ± 25 (SEM), n = 110} as those trans-
fected with non-targeting siRNA. In summary, these results dem-
onstrate that Myo1G contributes to cell elasticity in a non-
redundant manner with other class I myosin’s in Jurkat cells.Fig. 4. Knockdown of Myo 1G and expression of other class I myosins in Jurkat cells.
Jurkat cells were transfected either with control siRNA or siRNA’s targeting different
regions of Myo1G mRNA using nucleofection. Seventy two hours post transfection
Jurkat cells were analysed. (A) Cell homogenates were subjected to immunoblotting
to determine the levels of Myo1G depletion and the expression of Myo1B, Myo1C,
Myo1D, Myo1E and b-actin. Homogenates of the cell lines 293T, Caco-2 and
16HBE14O were used as positive antibody controls. (B) Transfection efﬁciency was
determined by transfecting Jurkat cells with FITC-labelled siRNA. Cellular uptake of
FITC was analysed by FACS.4. Discussion
The new ﬁndings of this study are that Myo1G is expressed spe-
ciﬁcally in haematopoietic cells, associates with the plasma mem-
brane, both the tail homology motif and the head domain
contribute to plasma membrane targeting, and depletion of Myo1G
reduces cell elasticity.
Myo1G is expressed in various immune cells important for in-
nate and adaptive immune responses. It is localized speciﬁcally
at the plasma membrane and therefore, is likely to link the plasma
membrane dynamically with actin ﬁlaments. An identical localiza-
tion of recombinant Myo1G was also observed in cells that do not
normally express Myo1G. This observation excludes the notionthat there is a receptor speciﬁcally expressed in immune cells.
Class I myosins have been reported to interact with anionic phos-
pholipids [3,4,7,25] and mammalian Myo1c has been shown to
interact with phosphoinositides in vivo [6]. The binding site was
mapped to a putative PH-domain that is identical to a previously
described myosin class I tail homology motif [24]. This putative
PH-domain is also necessary for the binding of Myo1G to the plas-
ma membrane. The mutation of two positively charged residues in
this domain abolished plasma membrane localization of Myo1G.
However, the putative PH-like domain is not sufﬁcient for tight
plasma membrane association. We found that the myosin head do-
main contributes signiﬁcantly to plasma membrane localization.
Interestingly, this does not need to be a head domain with a func-
tional ATPase cycle. A point mutation expected to abrogate ATP-
hydrolysis did not affect localization and a point mutation that
blocks nucleotide-binding increased only slightly the cytosolic
localization. The ﬁrst mutation is expected to block the ATPase cy-
cle in a nucleotide state exhibiting a weak afﬁnity for F-actin
whereas the second mutation is predicted to induce a nucleotide
state with a strong afﬁnity for F-actin. Therefore, the contribution
of the head domain to plasma membrane association appears not
to be strictly coupled with F-actin-binding. The head domain might
serve a more structural role in plasma membrane association, such
Fig. 5. Jurkat cells were transfected either with control siRNA or siRNA’s targeting different regions of Myo1G mRNA using nucleofection. Seventy two hours post transfection
Jurkat cells were used for elasticity measurement. (A) Schematic representation of indentation of Jurkat cells by a spherical glass bead mounted to an AFM cantilever. (B)
Representative force–indentation curves of control siRNA and Myo1G siRNA treated cells. (C) Young’s modulus (E) of untransfected, control siRNA and Myo1G siRNA treated
cells. Mean ± SEM are given; *P < 0.01, ‘n’ indicates the numbers of cells analysed.
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through the nuclear pores. Alternatively, the lack of the head do-
main might expose either a cryptic nuclear localization sequence
or a speciﬁc nuclear binding site.
We found that the knockdown of Myo1G reduced the elasticity
of Jurkat cells. The determined elasticity of 0.6 kPa for Jurkat cells is
well within the range of values determined previously for Jurkat
and other cells [26,12]. The knockdown of Myo1G most likely de-
creases cell elasticity by reducing internal tension on the actin cor-
tex. We showed that Jurkat cells express in addition to Myo1G also
Myo1b, Myo1c and Myo1e. The class I myosins Myo1a, Myo1b and
Myo1c have been shown to act as force sensors. Their chemical
ATPase cycle can be tuned by mechanical force [27–29]. The re-
lease of ADP is slowed signiﬁcantly by load and as a consequence
these class I myosins remain attached to F-actin for extended peri-
ods of time, because myosins in the ADP-bound state have a high
afﬁnity for F-actin. However, it is currently not known if Myo1G
exhibits similar strain-sensitive motor properties. Unlike for the
load-sensitive class I myosins, there was no additional small step
noted upon ADP release in single molecule mechanical measure-
ments for the most closely related class I myosin Myo1d [30].
Interestingly, overexpression of each of the mammalian myosins
1a, b, c, d and e caused an increase in membrane tension [15].
Therefore, it appears possible that the other class I myosins ex-
pressed in Jurkat cells also contribute to cell elasticity. However,
they cannot compensate for the contribution of Myo1G. This is
somewhat different from ﬁndings in D. discoideum cells. In these
cells cortical tension was altered only when at least two different
class I myosins were deleted simultaneously [14].In conclusion, Myo1G participates in the regulation of cell elas-
ticity in haematopoietic cells.
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